Stemming from our results of differential PIEZO1 expression levels in different subtypes of breast cancer, we then divided the TCGA cohort into breast cancer subtypes characterized by HR status and HER2 status to examine survival. This evidence concerns the gene ERBB2 and breast carcinoma.